{ "case_number": "CAC-UDRP-108404", "time_of_filling": "2026-02-11 09:36:23", "domain_names": [ "boehringer-ingelheimmx.com" ], "case_administrator": " Iveta Špiclová (Czech Arbitration Court) (Case admin)", "complainant": [ "Boehringer Ingelheim Pharma GmbH & Co.KG" ], "complainant_representative": "NAMESHIELD S.A.S.", "respondent": [ "Eugenio Chavez Hernandez (Raam Laboratorios)" ], "respondent_representative": null, "factual_background": "

The Complainant is a German family-owned pharmaceutical group of companies with roots going back to 1885, when it was founded by Albert BOEHRINGER INGELHEIM (1861-1939) in Ingelheim am Rhein. Ever since, BOEHRINGER INGELHEIM has become a global research-driven pharmaceutical enterprise and has around 54,500 employees. It is divided into two business areas: Human Pharma and Animal Health. In 2024, BOEHRINGER INGELHEIM achieved net sales of 26,796 billion euros.<\/p>\n

The disputed domain name <boehringer-ingelheimmx.com> was registered on February 9, 2026 and resolves to the Complainant's official website. <\/p>", "other_legal_proceedings": "

The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain name.<\/p>", "no_response_filed": "

COMPLAINANT<\/p>\n

The Complainant contends that the requirements of the Policy have been met and that the disputed domain name should be transferred to it. It states in particular that:<\/p>\n

    \n
  1. The disputed domain name <boehrinqer-ingelheimmx.com> is confusingly similar to its trademark BOEHRINGER INGELHEIM and is impersonating it by resolving the disputed domain name resolves to the Complainant’s official website at https:\/\/www.boehringer-ingelheim.com\/<\/a>. <\/li>\n<\/ol>\n
      \n
    1. It has no business relationship with the Respondent, who is identified as Eugenio Chavez Hernandez residing in Mexico and did not authorize him to register the disputed domain name;<\/li>\n<\/ol>\n
        \n
      1. The Respondent lacks rights or legitimate interests in the disputed domain name; and<\/li>\n<\/ol>\n
          \n
        1. Registered and is using the disputed domain name in bad faith and suggests that because the disputed domain name has been set up with MX records and it may be used for fraudulent purposes.<\/li>\n<\/ol>\n

          RESPONDENT:<\/p>\n

          The Respondent has not appeared formally or informally to controvert the evidence submitted by the Complainant.<\/p>", "rights": "

          The Complainant has, to the satisfaction of the Panel, shown the disputed domain name is identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).<\/p>", "no_rights_or_legitimate_interests": "

          The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy).<\/p>", "bad_faith": "

          The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).<\/p>", "procedural_factors": "

          The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.<\/p>", "decision": "Accepted", "panelists": [ "Gerald Levine Ph.D, Esq." ], "date_of_panel_decision": "2026-03-16 00:00:00", "informal_english_translation": "

          The Complainant owns a large portfolio of trademarks for the term “BOEHRINGER INGELHEIM” in several countries, including:<\/p>\n

          The international trademark BOEHRINGER INGELHEIM -INGELHEIM n°221544, registered since July 2, 1959; and the international trademark BOEHRINGER INGELHEIM n°568844 registered since March 22, 1991<\/p>", "decision_domains": { "boehringer-ingelheimmx.com": "TRANSFERRED" }, "panelist": null, "panellists_text": null }